NOVOZYMES A/S NAM. B DK 2 | 56.020 / +4.20% |
News
- Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022
02/01/2022 / 08:01 - GlobeNewswire - Closing the gap between sustainability and profits in corn wet milling
12/16/2021 / 10:04 - GlobeNewswire - Novozymes and Saipem enter collaboration agreement to create a more sustainable CO2 capture
12/13/2021 / 08:02 - GlobeNewswire - Novozymes strengthens and accelerates its BioHealth-business by acquiring a majority stake in Synergia Life Sciences, a leading developer and manufacturer of probiotics and vitamin K2-7
11/30/2021 / 10:34 - GlobeNewswire - Novozymes is unlocking growth by delivering strong Q3 results and increasing full-year guidance
10/26/2021 / 13:23 - GlobeNewswire - Novozymes is unlocking growth with the ambition of doubling company revenue by 2030
09/27/2021 / 19:19 - GlobeNewswire - Novozymes is combining cutting-edge science and business expertise to help feed the world sustainably
09/21/2021 / 12:17 - GlobeNewswire - New enzyme expands the role of biological ingredients for laundry detergents
09/15/2021 / 08:59 - GlobeNewswire - Novozymes delivers strong Q2 results and narrows full-year guidance to the high-end of the range
08/12/2021 / 07:59 - GlobeNewswire - Novozymes delivers solid Q1 results with 3% organic sales growth and strong earnings
04/27/2021 / 07:58 - GlobeNewswire - Novozymes acquires data science platform of Biota to strengthen microbiome R&D capabilities in probiotic development
03/11/2021 / 17:56 - GlobeNewswire - Novozymes delivers resilient full-year results despite the COVID-19 pandemic and is confident about getting back to growth in 2021
02/02/2021 / 08:02 - GlobeNewswire